What's in MedDerm Associates's pipeline?

MedDerm Associates has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with MedDerm Associates's portfolio?

Top competitors by shared drug class: Zurita Laboratorio Farmaceutico Ltda..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/medderm-associates.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

MedDerm Associates — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MedDerm Associates pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Acne Free, Proactiv	Acne Free, Proactiv	marketed	Topical acne treatment combination	Cutibacterium acnes; follicular keratinocytes	Dermatology

Therapeutic area mix

Dermatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Zurita Laboratorio Farmaceutico Ltda. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for MedDerm Associates:

Cite this brief

Drug Landscape (2026). MedDerm Associates — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/medderm-associates. Accessed 2026-06-10.